Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (391-400 of 628) with videos related to

Pageof 63
Sort By:
Leukemia & Lymphoma|July 17, 2012
Tertiary center referral patterns for patients with myelodysplastic syndrome are indicative of age and race disparities: a single-institution experienceDan P Zandberg, Franklin Hendrick, Emily Vannorsdall, et al.
The EMBO Journal|February 1, 1990
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix proteinQ Chen, J T Cheng, L H Tasi, et al.
Investigational New Drugs|February 28, 2013
Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndromeIvana Gojo, Alexander Perl, Selina Luger, et al.
Journal of the American Veterinary Medical Association|July 19, 2018
Investigation and characterization of Brucella canis infections in pet-quality dogs and associated human exposures during a 2007-2016 outbreak in MichiganCheri A Johnson, Todd D Carter, John R Dunn, et al.
Cancer|July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemiaJorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemiaHans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
ACS Nano|August 25, 2012
In situ TEM study of lithiation behavior of silicon nanoparticles attached to and embedded in a carbon matrixMeng Gu, Ying Li, Xiaolin Li, et al.
Leukemia|December 15, 2010
Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemiaL Yu, J C Reader, C Chen, et al.
Journal of Hematopathology|October 9, 2018
High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based RegimenZeba N Singh, Vu H Duong, Rima Koka, et al.
Particle and Fibre Toxicology|January 26, 2018
ISD3: a particokinetic model for predicting the combined effects of particle sedimentation, diffusion and dissolution on cellular dosimetry for in vitro systemsDennis G Thomas, Jordan N Smith, Brian D Thrall, et al.
Pageof 63

Showing results (391-400 of 628) with videos related to

Sort By:
Pageof 63
Leukemia & Lymphoma|July 17, 2012
Tertiary center referral patterns for patients with myelodysplastic syndrome are indicative of age and race disparities: a single-institution experienceDan P Zandberg, Franklin Hendrick, Emily Vannorsdall, et al.
The EMBO Journal|February 1, 1990
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix proteinQ Chen, J T Cheng, L H Tasi, et al.
Investigational New Drugs|February 28, 2013
Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndromeIvana Gojo, Alexander Perl, Selina Luger, et al.
Journal of the American Veterinary Medical Association|July 19, 2018
Investigation and characterization of Brucella canis infections in pet-quality dogs and associated human exposures during a 2007-2016 outbreak in MichiganCheri A Johnson, Todd D Carter, John R Dunn, et al.
Cancer|July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemiaJorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemiaHans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
ACS Nano|August 25, 2012
In situ TEM study of lithiation behavior of silicon nanoparticles attached to and embedded in a carbon matrixMeng Gu, Ying Li, Xiaolin Li, et al.
Leukemia|December 15, 2010
Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemiaL Yu, J C Reader, C Chen, et al.
Journal of Hematopathology|October 9, 2018
High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based RegimenZeba N Singh, Vu H Duong, Rima Koka, et al.
Particle and Fibre Toxicology|January 26, 2018
ISD3: a particokinetic model for predicting the combined effects of particle sedimentation, diffusion and dissolution on cellular dosimetry for in vitro systemsDennis G Thomas, Jordan N Smith, Brian D Thrall, et al.
Pageof 63